Hence, CCH provides support at the patient, clinician and service level. In this paper we describe the development and evaluation of an SMP for patients with a LTC. CCH Clinician self-management support practices are reported elsewhere [14] and [15]. The primary aim of this evaluation was to see whether

the SMP improved patient activation, which refers to the extent that patients have the knowledge, skills, and confidence, to use self-management Selleck NVP-BEZ235 support skills in their lives [16]. The evaluation also looked at whether the SMP improved health related quality of life, health status, mental health and self-management skills. Each of the CCH demonstration sites spanned Cabozantinib chemical structure primary and secondary care. CCH focused on four LTCs: chronic obstructive pulmonary disease (COPD), depression, diabetes, and musculoskeletal pain across

eight NHS sites, with two sites each focusing on the same condition. LTC patients seen in primary or secondary care settings were informed by their healthcare provider about the SMP. LTC patients’ inclusion criteria were to be over 18 years of age, have one of the four LTCs of interest (COPD, depression, diabetes and pain) and be physically able to attend a seven session group-based SMP. The SMP was delivered for groups of patients with the same LTC, so that patients recruited from COPD sites attended a COPD specific SMP, and the same applied for the other three conditions. Patients’ comorbid status was not a factor for recruitment to the SMP. Data were collected from patients who attended SMPs between 2007 and 2011. The study protocol was approved by the Brighton and Hove City Teaching PCT Multi Center Research Ethics Committee 07/H1107/143.

Patients who wished to attend the SMP registered their interest via a dedicated recruitment Methocarbamol telephone helpline. The contact details of patients who consented to take part in the evaluation were passed to the evaluation team. Pre-course questionnaires (Time 1) were mailed out to patients by the evaluation team. Reminder and follow-up calls prior to attendance were made to improve response rates. In keeping with the real world setting of the evaluation, LTC patients who chose not to participate in the evaluation were not excluded from the SMP. All patients were mailed out 6 month follow-up questionnaires (Time 2). Two reminder follow-up contacts were made. During the second attempt patients were offered the option to verbally complete the primary outcome measure, the Patient Activation Measure. The Health Foundation commissioned the Expert Patient Program Community Interest Company to develop the SMP. The Co-Creating Health SMPs are four condition specific programs, which are supplemented by generic core modules and activities (e.g. goal setting, problem solving, and relaxation).